Kevin Rosenthal

Kevin Rosenthal has nearly 30 years of pharmaceutical industry experience. Over his career, Kevin has successfully launched and managed several CDMO business units focused on and IND enabling drug product development and GMP clinical manufacturing within the US and Canada. Kevin initiated his career with Dura and Elan Pharmaceuticals developing inhaled drug products before transitioning to various CDMO leadership positions, including at Pharmatek/Catalent and Eurofins Canada, where he established and led profitable CDMO business units. Additionally, Kevin has designed and lead over 10 GMP facility build projects focused on oral drug product and clinical packaging operations in the US and Canada. Kevin is a graduate of San Diego State University with continuing education from the University of California San Diego.